Blood Metabolites Associate with Prognosis in Endometrial Cancer

Elin Strand, Ingvild L. Tangen, Kristine E. Fasmer, Havjin Jacob, Mari K. Halle, Erling A. Hoivik, Bert Delvoux, Jone Trovik, Ingfrid S. Haldorsen, Andrea Romano, Camilla Krakstad*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number302
Number of pages15
JournalMetabolites
Volume9
Issue number12
DOIs
Publication statusPublished - Dec 2019

Keywords

  • metabolomics
  • biomarker
  • endometrial cancer
  • VISCERAL ADIPOSE-TISSUE
  • NEOADJUVANT CHEMOTHERAPY
  • METABOLOMIC SIGNATURE
  • BIOMARKERS
  • METHIONINE
  • CELLS
  • SERUM
  • GENE

Cite this

Strand, E., Tangen, I. L., Fasmer, K. E., Jacob, H., Halle, M. K., Hoivik, E. A., Delvoux, B., Trovik, J., Haldorsen, I. S., Romano, A., & Krakstad, C. (2019). Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites, 9(12), [302]. https://doi.org/10.3390/metabo9120302